French CAR-T biotech Mnemo Therapeutics shuttered its U.S. operations. Mnemo turned the lights off at its US operations effective immediately on Feb. 23, according to employees’ posts on LinkedIn and confirmation from co-founder and operating chief Alain Maiore. (Endpoints News)

Merck’s experimental heart drug sotatercept showed efficacy in boosting exercise capacity in patients with pulmonary arterial hypertension in new trial results. Merck acquired sotatercept from Acceleron Pharma in a $11.5 billion buyout. (Reuters)

MMR vaccine rates have lagged amid a rise in measles cases and public health experts have blamed a discredited study. Numerous outbreaks of measles have popped up — in the U.K. and in the U.S. — over the last two decades, vaccination rates have fallen from their peaks and a recent Gallup poll found 10% of Americans do think vaccines cause autism. (ABC News)

Eli Lilly’s move to cap insulin prices will help it avoid Medicaid penalties for hiking up the price of its drugs faster than the rate of inflation. By reducing the price of its insulin Humalog by 70%, it won’t face such penalties. (STAT News)

A study found that a statin alternative – bempedoic acid – is effective at slashing cholesterol. The medication may be a safe alternative for people who want to avoid the muscle aches of statins, researchers say. (The New York Times)